Compare BFLY & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BFLY | EVO |
|---|---|---|
| Founded | 2011 | 1993 |
| Country | United States | Germany |
| Employees | 190 | 4766 |
| Industry | Medical Electronics | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 929.6M | 821.2M |
| IPO Year | N/A | N/A |
| Metric | BFLY | EVO |
|---|---|---|
| Price | $3.96 | $2.45 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | $4.88 | ★ $7.00 |
| AVG Volume (30 Days) | ★ 5.7M | 115.5K |
| Earning Date | 05-01-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $16.64 | N/A |
| Revenue Next Year | $22.37 | $7.13 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.32 | $2.31 |
| 52 Week High | $5.03 | $4.80 |
| Indicator | BFLY | EVO |
|---|---|---|
| Relative Strength Index (RSI) | 54.38 | 29.39 |
| Support Level | $3.59 | N/A |
| Resistance Level | $4.03 | $3.78 |
| Average True Range (ATR) | 0.31 | 0.09 |
| MACD | 0.06 | -0.07 |
| Stochastic Oscillator | 37.29 | 11.40 |
Butterfly Network Inc is a digital health business transforming care with handheld, whole-body ultrasound. Powered by its proprietary Ultrasound-on-Chip technology, its solution enables the acquisition of imaging information from an affordable, powerful device that fits in a healthcare professional's pocket with a combination of cloud-connected software and hardware technology that is easily accessed through a mobile application. The company enables the practical application of ultrasound information in the clinical workflow. Butterfly iQ+ is an ultrasound device that can perform whole-body imaging in a single handheld probe using semiconductor technology. With its small, handheld size, low cost, and simple user interface.
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.